Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements.

about

Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements.

Item

http://www.wikidata.org/entity/Q55024047

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Successful treatment of refrac ...... r using thyroxine supplements.

@en

Successful treatment of refrac ...... r using thyroxine supplements.

@nl

type

Item

label

Successful treatment of refrac ...... r using thyroxine supplements.

@en

Successful treatment of refrac ...... r using thyroxine supplements.

@nl

prefLabel

Successful treatment of refrac ...... r using thyroxine supplements.

@en

Successful treatment of refrac ...... r using thyroxine supplements.

@nl

P1476

Successful treatment of refrac ...... or using thyroxine supplements

@en

P2093

Kazuo Ono

http://www.w3.org/2001/XMLSchema#string

Masaharu Nohgawa

http://www.w3.org/2001/XMLSchema#string

P2860

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

[Efficacy of rituximab for TAFRO syndrome, a variant type of multicentric Castleman's disease].

[Autoimmune hemolytic anemia in a patient with TAFRO syndrome].

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease.

Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.

International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.

Molecular and biological properties of the vascular endothelial growth factor family of proteins.

Castleman disease and associated autoimmune disease.

Idiopathic multicentric Castleman's disease: a systematic literature review.

P304

644-650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1002/CCR3.1430

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Satoko Oka

P577

2018-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29636932

http://www.w3.org/2001/XMLSchema#string

P932

5889265

http://www.w3.org/2001/XMLSchema#string